Skip to main content
Clinical Trials/NCT00721097
NCT00721097TerminatedNot Applicable

Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics

Nantes University Hospital1 site in 1 country40 target enrollmentStarted: June 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
40
Locations
1
Primary Endpoint
Number of predictive factors for exacerbation outcome in severe asthmatics.

Study Overview

Brief Summary

Asthma is a chronic inflammatory disease, affecting up to 10 % of the general population in developed countries. Corticosteroids are necessary to control symptoms, but induce adverse events sometimes intolerable. In severe asthma, which represent 5 to 10% of global asthma, corticosteroids frequently fail to prevent severe exacerbations, leading to emergency care, hospitalization and sometimes death. The aim of this study is to identify predictive factors specific for exacerbation outcome which will lead to a minor increase in treatment in order to prevent exacerbations, while minimizing drug adverse effects.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of predictive factors for exacerbation outcome in severe asthmatics.

Secondary Outcomes

  • Rate of predictive factors identified in the study, in order to prevent exacerbations.

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials